10
IRUS Total
Downloads

Unlocking the KLK activome in drug-resistant prostate cancer: biomarker discovery and target validation




COUNTER-compliant statistics provided by IRUS-UK.
Unless otherwise indicated, items in Spiral are protected by copyright and are licensed under a Creative Commons Attribution NonCommercial NoDerivatives License.